The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type

Age and Ageing

Volumn 25, Issue 6, 1996, Pages 443-448

  Amar, K ^a   Bucks, R S ^b   Lewis, T ^a   Scott, M ^b   Wilcock, G K ^a  

^a FRENCHAY HOSPITAL   (United Kingdom)

^b BLACKBERRY HILL HOSPITAL   (United Kingdom)

Author keywords

Dementia; Leuko araiosis; White matter low attenuation

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; ATTENTION; COGNITION; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DEPTH PERCEPTION; FEMALE; FRONTAL LOBE; HUMAN; LEUKOARAIOSIS; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; OCCIPITAL LOBE; PRIORITY JOURNAL; VELOCITY; VISUAL MEMORY; WHITE MATTER;

EID: 0029989426     PISSN: 00020729     EISSN: None     Source Type: Journal    
DOI: 10.1093/ageing/25.6.443     Document Type: Article

References (33)

1. Hachinski VC, Potter P, Merskey H. Leuko-araiosis. Arch Neurol 1987;44:21-3.
2. George AE, De Leon MJ, Gentes CI, et al. Leukoencephalopathy in normal and pathologic aging. AJNR 1986; 7:561-6.
3. Rezek DL, Morris JC, Fulling KH, Gado MH. Periventricular white matter lucencies in senile dementia of the Alzheimer type and normal aging. Neurology 1987;37: 1365-8.
4. Kobari M, Meyer JS, Ichijo M. Leuko-araiosis, cerebral atrophy and cerebral perfusion in normal aging. Arch Nurol 1990;47:161-5.
5. Inzitari D, Diaz F, Fox A, et al. Vascular risk factors and leukoaraiosis. Arch Neurol 1987;44:42-7.
6. Blennow K, Wallin A, Uhlemann C, Gottfries CG. White matter lesions on CT in Alzheimer patients: relation to clinical symptomatology and vascular factors. Acta Neurol Scand 1991;83:187-93.
7. Raiha I, Tarvonen S, Kurki T, Rajala T, Sourander L. Relationship between vascular risk factors and white matter low attenuation of the brain. Acta Neurol Scand 1993;87:286-9.
8. Amar K, Lewis T, Wilcock GK, Scott M, Bucks R. The relationship between white matter low attenuation on brain CT and vascular risk factors: a memory clinic study. Age Ageing 1995;24:411-15.
9. Rao SM, Mittenberg W, Bernardin L, Haughton V, Leo G. Neuropsychological test findings in subjects with leuko-araiosis. Arch Neurol 1989;46:40-4.
10. Hunt AL, Orrison WW, Yeo RA, et al. Clinical significance of MRI white matter lesions in the elderly. Neurology 1989;39:1470-4.
11. Gupta SR, Naheedy MH, Young JC, et al. Periventricular white matter changes and dementia. Arch Neurol 1988;45:637-41.
12. Steingart A, Hachinski VC, Lau C, et al. Cognitive and neurologic findings in demented patients with diffuse white matter leucencies on computed tomographic scan. Arch Neurol 1987;44:36-9.
13. Schmidt R, Fazekas F, Offenbacher H, et al. Neuropsychological correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 1993;43:2490-4.
14. Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R. White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 1993;50:818-24.
15. Amar K, Wilcock GK. Vascular dementia. Neurology 1995;45:1423-5.
16. Amar K, Wilcock GK, Scott M. The diagnosis of vascular dementia in the light of the new criteria. Age Ageing 1996;25:51-5.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. rev. Washington, DC: American Psychiatric Association, 1987.
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services task force on Alzheimer's disease. Neurology 1984;34:939-44.
19. Hare M. Clinical checklist for diagnosis of dementia. BMJ 1978;2:266-7.
20. Folstein FM, Folstein SE, McHugh PR, et al. Minimental state - a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98.
21. Wechsler Adult Intelligence Scale. New York: The Psychological Corporation, 1955.
22. Enderby P, Wood V, Wade D. Frenchay Aphasia Screening Test (FAST). Test manual. Winsor: NFER-Nelson, 1987.
23. Kenrick D. Kenrick cognitive tests for the elderly. Windsor: NFER-Nelson, 1985.
24. Lezak MD. Neuropsychological assessment. New York: Oxford University Press, 1983.
25. Almkvist O, Wahlund LO, Anderson-Lundman G, Basun H, Backman L. White matter hyperintensity and neuropsychological functions in dementia and healthy aging. Arch Neurol 1992;49:626-32.
26. Breteler MB, van Swieten JC, Bots ML, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population based study: the Rotterdam study. Neurology 1994;44:1246-52.
27. Lopez OL, Becker JT, Rezek D, et al. Neuropsychiatric correlates of cerebral white matter radiolucencies in probable Alzheimer's disease. Arch Neurol 1992;47: 828-34.
28. Kertesz A, Polk M, Carr T. Cognition and white matter changes on magnetic resonance imaging in dementia. Arch Neurol 1990;47:387-91.
29. Boone KB, Miller BL, Lesser IM, et al. Neuropsychological correlates of white matter lesions in healthy elderly subjects - a threshold effect. Arch Neurol 1992; 49:549-54.
30. Damian MS, Schilling G, Bachmann G, Simon C, Stoppler S, Dorndorf W. White matter lesions and cognitive deficits: relevance of lesion pattern. Acta Neurol Scand 1994;90:430-6.
31. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986;19:253-62.
32. Janota I, Mirsen TR, Hachinski VC, Lee DH, Merskey H. Neuropathologic correlates of leuko-araiosis. Arch Neurol 1989;46:1124-8.
33. Gray F, Dubas F, Roult E, Escourolle R. Leukoencephalopathy in diffuse haemorrhagic amyloid angiopathy. Ann Neurol 1985;18:54-9.